- Symrise anticipates its EBITDA margin to be above 20% for the fiscal year. Previously, it was around 20%.
- The company expects organic sales growth to exceed 7%, with previous figures also around 7%. Analyst estimates suggest a possible 9.54% growth.
- For 2025, Symrise targets continuous organic sales growth between 5-7% CAGR, and an EBITDA margin ranging from 20-23%.
- Business free cash flow is targeted to achieve 14% in 2025.
- Long-term goals, extending to 2028, include maintaining organic sales growth at 5-7% CAGR and adjusting the EBITDA margin target to 21-23% (from a prior 20-23%).
- The company plans to exceed 14% in business free cash flow over the long term.
- Current analyst recommendations for Symrise are mixed: 12 analysts indicate a “buy,” 12 recommend “hold,” and 1 suggests “sell.”
“`
A look at Symrise AG Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Symrise AG has a positive long-term outlook. With strong scores in Growth, Resilience, and Momentum, the company appears well-positioned for future success. Symrise AG‘s focus on innovation and expanding market presence contributes to its favorable Growth score, indicating potential for continued expansion. Additionally, the company’s ability to adapt to market changes and maintain a steady performance reflects in its Resilience score. The Momentum score suggests that Symrise AG is gaining traction and investor interest, further supporting its promising outlook.
Symrise AG, a diversified chemical manufacturer, produces a wide range of products including perfume oils, fragrance bases, and cosmetic raw materials. Serving customers in various industries such as fragrances, cosmetics, foods, and pharmaceuticals, Symrise AG demonstrates its versatility and broad market reach. With solid ratings in key areas like Growth and Resilience, Symrise AG‘s strategic positioning and product offerings bode well for its future performance and sustainability in the market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
